191 related articles for article (PubMed ID: 32993744)
1. Response to "Co-infections in COVID-19 critically ill and antibiotic management: a prospective cohort analysis".
Nieuwenhuis MB; Van Biesen S; Juffermans NP
Crit Care; 2020 Sep; 24(1):591. PubMed ID: 32993744
[No Abstract] [Full Text] [Related]
2. Early administered antibiotics do not impact mortality in critically ill patients with COVID-19.
Buetti N; Mazzuchelli T; Lo Priore E; Balmelli C; Llamas M; Pallanza M; Elzi L; Consonni V; Trimboli P; Forni-Ogna V; Bernasconi E
J Infect; 2020 Aug; 81(2):e148-e149. PubMed ID: 32512022
[No Abstract] [Full Text] [Related]
3. Is previous influenza-like illness a potential Trojan horse for COVID-19?
Ceccarelli G; d'Ettorre G; Innocenti GP; Mastroianni CM; Ciccozzi M; d'Ettorre G
Crit Care; 2020 Aug; 24(1):503. PubMed ID: 32799917
[No Abstract] [Full Text] [Related]
4. Study of critically ill patients with COVID-19 in New York City.
Piovani D; Bonovas S
Lancet; 2020 Oct; 396(10257):1064. PubMed ID: 33038958
[No Abstract] [Full Text] [Related]
5. Study of critically ill patients with COVID-19 in New York City - Authors' reply.
Cummings MJ; O'Donnell MR
Lancet; 2020 Oct; 396(10257):1064. PubMed ID: 33038960
[No Abstract] [Full Text] [Related]
6. Response to 'Impact of immunosuppression on mortality in critically ill COVID-19 patients'.
Fox TA; Troy-Barnes E; Kirkwood AA; Chan WY; Day JW; Chavda SJ; Kumar EA; David K; Tomkins O; Sanchez E; Scully M; Khwaja A; Lambert J; Singer M; Roddie C; Morris EC; Yong KL; Thomson KJ; Ardeshna KM
Br J Haematol; 2020 Nov; 191(3):505-506. PubMed ID: 33103782
[No Abstract] [Full Text] [Related]
7. Critically ill patients with COVID-19 in New York City.
Grasselli G; Zanella A
Lancet; 2020 Jun; 395(10239):1740-1741. PubMed ID: 32442530
[No Abstract] [Full Text] [Related]
8. Inhaled nitric oxide for critically ill Covid-19 patients: a prospective study.
Abou-Arab O; Huette P; Debouvries F; Dupont H; Jounieaux V; Mahjoub Y
Crit Care; 2020 Nov; 24(1):645. PubMed ID: 33183348
[No Abstract] [Full Text] [Related]
9. Preliminary therapeutic drug monitoring data of β-lactams in critically ill patients with SARS-CoV-2 infection.
Novy E; Scala-Bertola J; Roger C; Guerci P
Anaesth Crit Care Pain Med; 2020 Jun; 39(3):387-388. PubMed ID: 32315803
[No Abstract] [Full Text] [Related]
10. Aerosol Barrier Hood for Use in the Management of Critically Ill Adults With COVID-19.
Martel ML; Reardon RF
Ann Emerg Med; 2020 Sep; 76(3):370-371. PubMed ID: 32534831
[No Abstract] [Full Text] [Related]
11. Mobile X-rays are highly valuable for critically ill COVID patients.
Wu G; Li X
Eur Radiol; 2020 Sep; 30(9):5217-5219. PubMed ID: 32405750
[No Abstract] [Full Text] [Related]
12. Critically ill patients with COVID-19 and candidaemia: We must keep this in mind.
Agrifoglio A; Cachafeiro L; Figueira JC; Añón JM; García de Lorenzo A
J Mycol Med; 2020 Dec; 30(4):101012. PubMed ID: 32651137
[No Abstract] [Full Text] [Related]
13. Comment to: Intensive support recommendations for critically-ill patients with suspected or confirmed COVID-19 infection.
Corrêa TD; Matos GFJ; Bravim BA; Cordioli RL; Garrido ADPG; Assuncao MSC; Barbas CSV; Timenetsky KT; Rodrigues RDR; Guimarães HP; Rabello Filho R; Lomar FP; Scarin FCC; Batista CL; Pereira AJ; Guerra JCC; Carneiro BV; Nawa RK; Brandão RM
Einstein (Sao Paulo); 2020; 18():eCE5931. PubMed ID: 32785567
[No Abstract] [Full Text] [Related]
14. Clinical course of severe and critically ill patients with coronavirus disease 2019 (COVID-19): A comparative study.
Chen L; Zhang B; Ti MN; Yang K; Zou Y; Zhang S
J Infect; 2020 Aug; 81(2):e82-e84. PubMed ID: 32405109
[No Abstract] [Full Text] [Related]
15.
Zhang J; Wang H; Dong L
Telemed J E Health; 2020 Jul; 26(7):853-854. PubMed ID: 32315253
[No Abstract] [Full Text] [Related]
16. Impactful Policy Action to Reduce Drug Costs in Managing Critically Ill Patients with COVID-19.
Tichy EM; Francis JR
Mayo Clin Proc; 2020 Aug; 95(8):1808-1809. PubMed ID: 32753159
[No Abstract] [Full Text] [Related]
17. Cluster of chalazia in nurses using eye protection while caring for critically ill patients with COVID-19 in intensive care.
Mégarbane B; Tadayoni R
Occup Environ Med; 2020 Aug; 77(8):584-585. PubMed ID: 32467314
[No Abstract] [Full Text] [Related]
18. Presence of SARS-CoV-2 in urine is rare and not associated with acute kidney injury in critically ill COVID-19 patients.
Frithiof R; Bergqvist A; Järhult JD; Lipcsey M; Hultström M
Crit Care; 2020 Sep; 24(1):587. PubMed ID: 32993742
[No Abstract] [Full Text] [Related]
19. Severe immune thrombocytopenia in a critically ill COVID-19 patient.
Martincic Z; Skopec B; Rener K; Mavric M; Vovko T; Jereb M; Lukic M
Int J Infect Dis; 2020 Oct; 99():269-271. PubMed ID: 32771636
[TBL] [Abstract][Full Text] [Related]
20. Re: Cluster of chalazia in nurses using eye protection while caring for critically ill patients with COVID-19 in intensive care.
Beck DER; Agarwal P
Occup Environ Med; 2020 Nov; 77(11):808. PubMed ID: 32817294
[No Abstract] [Full Text] [Related]
[Next] [New Search]
